5

Sunil Healthcare

SUNLOC NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹77.42 Cr
Volatility
Moderate
P/E Ratio
21.63
EBITDA
₹12.65 Cr
Return on Equity
-2.11%
Debt to Equity
0.8
Book Value
₹51.56
52W High
₹82
52W Low
₹67.5

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Stock is trading at 1.11 times its book value

Weaknesses

4
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -0.65% over past five years.
  • Company has a low return on equity of 0.59% over last 3 years.
  • Company has high debtors of 188 days.

Growth Rate

Revenue Growth
3.44% higher than 3Y
Net Income Growth
-231% lower than 3Y
Cash Flow Change
175% higher than 3Y
ROE
-19.47% lower than 3Y
ROCE
66.04% higher than 3Y
EBITDA Margin (Avg.)
2.78% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
22.51
23.7
22.67
21.31
21.5
20.26
20.46
21.2
22.64
23.52
21.84
19.72
18.99
Expenses
21.69
22.48
23.3
18.63
19.29
17.95
17.76
18.17
19.37
19.59
18.22
17.78
16.06
Operating Profit
0.82
1.22
-0.63
2.68
2.21
2.31
2.7
3.03
3.27
3.93
3.62
1.94
2.93
OPM %
3.64%
5.15%
-2.78%
12.58%
10.28%
11.4%
13.2%
14.29%
14.44%
16.71%
16.58%
9.84%
15.43%
Other Income
1.19
0.22
3.13
0.68
0.14
0.18
0.53
0.49
0.86
0.42
0.5
0.29
0.23
Interest
1.27
1.31
1.44
1.76
1.51
1.5
1.89
1.56
1.44
1.4
1.66
1.66
1.5
Depreciation
1.61
1.59
1.45
1.43
1.48
1.51
1.69
1.68
1.66
1.64
1.62
1.52
1.46
PBT
-0.87
-1.46
-0.39
0.17
-0.64
-0.52
-0.35
0.28
1.03
1.31
0.84
-0.95
0.2
Tax %
-26.44%
-25.34%
-48.72%
5.88%
6.25%
7.69%
57.14%
-28.57%
11.65%
23.66%
30.95%
-258.95%
-130%
Net Profit
-0.64
-1.1
-0.2
0.15
-0.69
-0.55
-0.54
0.36
0.91
1
0.59
1.52
0.46
EPS in Rs
-0.62
-1.07
-0.2
0.15
-0.67
-0.54
-0.53
0.35
0.89
0.98
0.58
1.48
0.45
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
108
91.33
80.88
70.02
90.62
119
110
90.19
83.42
87.72
84.07
Expenses
93.33
77.44
69.62
76.95
85.27
102
94.32
85.93
73.06
74.95
71.65
Operating Profit
15.15
13.89
11.26
-6.93
5.35
17.38
16.17
4.26
10.36
12.77
12.42
OPM %
13.97%
15.21%
13.92%
-9.9%
5.9%
14.59%
14.63%
4.72%
12.42%
14.56%
14.77%
Other Income
1.25
2.23
0.18
14.41
5.52
1.68
4.5
5.05
1.24
2.06
1.44
Interest
4.18
5.03
6.58
6.95
5.31
3.49
4.17
5.78
6.46
6.16
6.22
Depreciation
4.33
4.78
5.74
6.13
6.11
6.31
7.01
6.09
6.35
6.44
6.24
PBT
7.89
6.31
-0.88
-5.6
-0.55
9.26
9.49
-2.56
-1.21
2.23
1.4
Tax %
36.25%
28.68%
-20.45%
-11.25%
16.36%
30.67%
29.5%
-30.08%
16.53%
-79.37%
—
Net Profit
5.03
4.49
-0.69
-4.96
-0.64
6.42
6.68
-1.79
-1.42
4.01
3.57
EPS in Rs
4.91
4.38
-0.67
-4.84
-0.62
6.26
6.51
-1.75
-1.38
3.91
3.49
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
10.25
10.25
10.25
10.25
10.25
10.25
10.25
10.25
10.25
10.25
Reserves
32.65
37.18
36.52
34.34
33.46
39.7
45.74
57.96
56.81
59.35
Borrowings
44.53
60.62
55.08
49.45
49.82
34.68
36.79
66.15
68.65
55.79
Other Liabilities
31.41
34.16
35.88
36.19
27.03
25.06
28.01
24.13
26.23
39.12
Total Liabilities
119
142
138
130
121
110
121
158
162
165
Fixed Assets
59.72
70.92
68.83
69.97
69.8
69.97
70.43
87.16
94.08
85.85
CWIP
0.12
0.19
2.47
0.01
0.01
1.75
0.01
5.66
0.09
1.77
Investments
0
0.1
0.11
0.11
1.07
1.03
0
0
0
0
Other Assets
59
71
66.32
60.14
49.68
36.94
50.35
65.67
67.77
76.89
Total Assets
119
142
138
130
121
110
121
158
162
165
Figures in ₹ Crores

Cash Flow

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
10.79
5.48
14.73
4.31
16.99
22.51
7.47
-15.4
11.52
22.15
Investing
-12.85
-17.18
-2.8
-2.52
-11.36
-4.24
-3.4
-10.11
-7.7
-2.85
Financing
2.23
11.02
-11.63
-1.56
-6.42
-18.56
-3.75
25
-3.87
-19.26
Net Cash Flow
0.17
-0.67
0.3
0.23
-0.79
-0.29
0.32
-0.51
-0.05
0.04
Free Cash Flow
-2.15
-10.13
9.22
3.63
10.28
13.49
3.99
-25.58
2.52
18.6
CFO/OP
82
50
134
-64
315
136
55
-344
111
173
Figures in ₹ Crores

Ratios

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
130
192
177
123
94.37
57.86
93.85
164
182
188
Inventory Days
76.09
102
213
323
117
83.25
105
111
176
209
Days Payable
139
180
294
293
109
65.01
114
47.85
88.79
178
Cash Conversion Cycle
66.75
114
96.04
153
102
76.09
84.96
227
269
219
Working Capital Days
-11.68
-16.43
-50.91
-63.65
-53.49
-25.91
-4.33
6.35
-2.54
21.6
ROCE %
—
11.6%
5.43%
1.65%
5.12%
14.25%
15.3%
2.98%
3.96%
6.52%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sunil Healthcare insights

65 extracted metrics + investor summaries across FY09–FY26.

Log in — free

Shareholding Pattern

DIIs0.10%Promot.73.53%Others8.48%Public17.89%As ofJun 2026

Documents

1
Concall - Jul 2021 Jul 2021
2
Concall - May 2021 May 2021
3
Concall - May 2021 May 2021
4
Concall - May 2021 May 2021
5
Concall - Feb 2021 Feb 2021

Frequently Asked Questions about Sunil Healthcare

What does Sunil Healthcare Ltd do?
Incorporated in 1976, Sunil Healthcare Ltd is a certified manufacturer of Empty Hard Gelatin capsules shell and HPMC Capsules shell.[1]
Where is Sunil Healthcare Ltd (537253) listed?
Sunil Healthcare Ltd trades as SUNLOC on the NSE and under code 537253 on the BSE.
Which sector does Sunil Healthcare Ltd belong to?
Sunil Healthcare Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Sunil Healthcare Ltd?
Sunil Healthcare Ltd has a market capitalisation of ₹77.42 Cr, which places it in the Small Cap band.
What is the PE ratio of Sunil Healthcare Ltd?
Sunil Healthcare Ltd trades at a PE ratio of 21.63, against a book value of ₹51.56 per share.
What is the 52-week high and low of Sunil Healthcare Ltd?
Over the last 52 weeks Sunil Healthcare Ltd has traded between ₹67.5 and ₹82.
What is the Return on Equity (ROE) of Sunil Healthcare Ltd?
Sunil Healthcare Ltd reported a return on equity of -2.11%. Its debt-to-equity ratio is 0.80.

Company Information

Incorporated in 1976, Sunil Healthcare Ltd is a certified manufacturer of Empty Hard Gelatin capsules shell and HPMC Capsules shell.[1]

Website sunilhealthcare.com
Listed 2026-08-17
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/537253.md for Sunil Healthcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List